General Information
Joomla! provides plenty of flexibility when displaying your Web content. Whether you are using Joomla! for a blog site, news or a Web site for a company, you'll find one or more content styles to showcase your information. You can also change the style of content dynamically depending on your preferences. Joomla! calls how a page is laid out a layout. Use the guide below to understand which layouts are available and how you might use them.
Citeline will be sponsoring Redox Medicine 2024
Citeline will be sponosring the the 26th International Conference on Redox Medicine 2024 on June 27-28, at Fondation Biermans-Lapôtre, Paris, France.
About Citeline
Citeline (a Norstella Company) powers a full suite of complementary business intelligence offerings to meet the evolving needs of health science professionals to accelerate the connection of treatments to patients and patients to treatments.
These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial, and regulatory related-decisions and create real-world opportunities for growth.
Our global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more.
Citeline Talk at Redox Medicine 2024
Pharma’s Search for Redox-Modulating Therapeutics
Duncan Emerton, Vice-President of Citeline, United Kingdom
What will you get from this session?
- Indications in which redox imbalance is linked to disease pathogenesis (e.g., long list)
- Key targets which modulate redox signalling in cellular homeostasis (e.g., NRF2/KEAP1, FOXO, NFkB, HIF, etc.)
- Pharma’s progress in developing medicines toward novel targets (i.e., stats from Citeline data sets by phase, company and indication)
- Outlook (i.e., how is redox medicine R&D likely to evolve?)
- Key Takeaways
Visit Citeline website:
www.citeline.com
Redox Medicine 2024 Venue & Hotel
Biermans-Lapôtre Foundation
Cité Internationale Universitaire de Paris
9A Boulevard Jourdan
75014 Paris, France
How to access
Nearest Metro/RER stations:
- Métro/RER: RER B -Cité Internationale
- Tramway: Tram 3 - Cité Internationale
Airports
The two main airports, Aeroport Roissy Charles de Gaulle (CDG) and Orly (ORY), are quite far from the Center of Paris.
To reach the Center you can :
- Take the Roissy bus from CDG to Place de l'Opéra (Paris II): Paris Airports website
- Take the train (RER and metro)
- Or Take a taxi
Parisian transports
You will find on this website map of the metro and RER, and some useful information about rates, and traffic,...
Tourist Office of Paris
All activities and information about the news of the moment in Paris are available on the tourist office website : Tourist Office website
If you have any further questions, don't hesitate to contact us.
Hotel Booking in Paris
Revolugo provides a broad selection of accommodations at highly competitive prices.
Revolugo is the sole official accommodation provider for the 26th International Conference on Redox Medicine 2024. Any other providers that may contact you could potentially be fraudulent.
Important Information
- RMS is not responsible for any aspect of your accommodation. Revolugo is the sole entity responsible for your bookings. If you have any questions, we recommend that you direct them to Revolugo.
- Each hotel proposed by Revolugo has its own cancellation and modification policies. We advise you to carefully review these policies before making your booking.
- If you need any assistance or encounter any problems with your booking, please don't hesitate to contact Revolugo via:
- Email : This email address is being protected from spambots. You need JavaScript enabled to view it.
- Tel: +33 (0)1 80 06 62 88 (9am to 7pm CEST).
Book your hotel in Paris with a negotiated price
Speakers of Redox Medicine 2024
|
Small Molecule Electrophiles: Lessons from a Journey along the Redox Chemistry of Nitrogen Oxides to Drug Development Bruce Freeman, University of Pittsburgh, USA |
Keynote Day 2 Redox Interactome in Physiopathology Miria Ricchetti, Institut Pasteur, France |
 Antioxidants Stimulate Blood Flow in Tumors Martin O. Bergo, Karolinska Institutet, Sweden |
 Mechanism of the SuperInflammasome Complexes in Human Diseases and Redox SignalingMario D. Cordero, Universidad Pablo de Olavide, Spain |
 Regulation of the Reactive Species Interactome by Prokineticin Antagonist in Cerebral DementiaChristel Marquette, Laboratoire Biosanté U1292 INSERM-CEA-UGA, Equipe MAB2, France |
 Epigenetic modulators link mitochondrial redox homeostasis to cardiac function in a sex-dependent mannerZaher El Beck, Karolinska Institutet and Uppsala University, Sweden |
|
Tamara Tomin, TU Wien, Austria |
 The Reactive Species Interactome, Mitochondria, and the Gender-Brain Metabolism NexusLaurent Chatre, ISTCT, CNRS, Université de Caen Normandie, France |
 NADH: The Redox Sensor in Aging-Related DisordersRoberta Rizzo, Università degli Studi di Ferrara, Italy |
 Redox Implications of Supplementary Oxygen during Major Abdominal SurgeryAndrew Cumpstey, University of Southampton, United Kingdom |
 New Insights into the Impact of Oxidative Stress in Hypertensive Diseases of PregnancyDaniel Vaiman, DR1 INSERM, Institut Cochin, France |
 Redox Medicine 2024: BiomarkersCarole Nicco, President of Redox Medicine Society |
 Identifying Oxidized Lipids in Neurodegenerative DiseasesSayuri Miyamoto, University of São Paulo, Brazil |
 Exploring Predictors of HDL Oxidative Stress Functionality in Post-Covid Disease and Relation to SeverityJumana Saleh, Sultan Qaboos University, Oman |
 Redox, Radiotherapy and BiomarkersRadia Tamarat, Institut de Radioprotection et de Sûreté Nucléaire (IRSN), France |
 Targeting the Keap1/Nrf2 Pathway for Treatment of Chronic Neurodegenerative DiseasesJeffrey A. Johnson, University of Wisconsin, USA |
 Antioxidant and Prooxidant Nanozymes: From Cellular Redox Regulation to Next-Generation TherapeuticsGovindasamy Mugesh, Indian Institute of Science, India |
|
George M. Spyrou, The Cyprus Institute of Neurology & Genetics, Cyprus |
|
Duncan Emerton, Vice-President of Citeline, United Kingdom |
 How to Develop a Drug – From Preclinical to ClinicalAntonio Vila-Coro, IQVIA, Spain |
 Artificial Intelligence in NeuroInflammation, Biomarkers and Redox MedicineStéphane Mouchabac, CHU St Antoine DMU Neurosciences and Institut du Cerveau, Paris |
 Artificial Intelligence & Algorithms: Applications in Redox Medicine & RadiologyMaxime Barat, Université Paris Cité, Hôpital Cochin, France |
Redox Medicine 2024 Agenda
Day 1 - June 27, 2024
Keynote Speech: Redox Medicine 2024: Where we are now and where we are heading?
Session 1: Redox Balance in Health & Disease
- Mechanistic Insights
- Role of Biomarkers
- Interplay of Biophysics, Biology, and Health
Session 2: Evaluation of Redox Status and Related Biomarkers
- Methods, Tools, Artificial Intelligence, Biosensors and Devices
- Hands-on Demonstrations with Industry Partners
Round-table Discussion with the RMS Scientific Board
Facilitating discussions on current challenges and opportunities in Redox Medicine.
Day 2 - June 28, 2024
Session 3: The Future of Redox Medicine 2024: Innovative Directions and Emerging Trends
- Biomarkers: Prevention and Diagnosis in Redox Medicine
- Small Synthetic, Natural Antioxidants & Redox Molecules
- Artificial Intelligence, Algorithms & Redox Medicine
- Iron, Redox & Ferroptosis: Innovations & Challenges
- Skin Redoxome
- Other relative topics
Session 4: Redox Medicine from Bench to Bedside, Companion Diagnostics
A collaborative session featuring insights from BioPharma, CRO, CDMO, and regulatory bodies.
Concluding Remarks
Redox Medicine 2024 Awards
Celebrating excellence with awards for:
- Best Scientific Contribution
- Best Short Oral Presentation
- Best Poster Presentation
